Analyzing the trends and forecasting Global Lung Cancer Therapeutics Analyzing the trends and forecasting Global Lung C | Page 5

5.1.1 Chemotherapy 5.1.1.1 Cisplatin 5.1.1.2 Taxol 5.1.1.3 Navelbine 5.1.1.4 Camptosar 5.1.1.5 Alimta 5.1.2 Radiotherapy 5.1.2.1 External Beam 5.1.2.2 Internal Beam 5.1.2.3 Systemic 5.1.3 Other Drugs 5.1.3.1 Abraxane 5.1.3.2 Avastin 5.1.3.3 Crizotinib 5.1.3.4 Docetaxel 5.1.3.5 Gefitinib 6 . Geographical Analysis 6.1 North America 6.1.1 Introduction 6.1.2 United States 6.1.3 Canada 6.2 Europe 6.2.1 Introduction 6.2.2 U . K 6.2.3 Spain 6.2.4 Germany 6.2.5 Italy 6.2.6 France 6.3 Asia-Pacific 6.3.1 Introduction 6.3.2 China 6.3.3 India 6.3.4 Japan